Items Tagged ‘multiple scleroris’

January 15, 2015

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations   TODAY A walk a day may keep […]

View full entry

Tags: 2014 Mankato Meltdown, 26.2 with Donna Marathon, 4029 TV, 5 KJZZ, ABC News, ABC15 Phoenix, Acento Veintiuno, advisory board, aging, American College of Cardiology, American Spectator, Anesthesia News


October 16, 2014

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations   Wall Street Journal Exercise, Diet and Sleep […]

View full entry

Tags: A.L.S., ABC-7 Fort Meyers/Naples, ABC15 Arizona, Advisory Board Daily Briefing, Anna Stoehr, Aspen Times, AT&T, Austin Daily Herald, Becker’s Spine Review, Bernice Youngman, Big Data to Knowledge, Billings Gazette


January 31, 2014

Mayo Clinic in the News Weekly Highlights

By Karl Oestreich

Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Modern Healthcare Symptoms, diagnosis and a prescription: How […]

View full entry

Tags: Aguas Digital.com, Albert Lea Tribune, alcohol, Amber Sherman, Ana Gregg, Anti-VEGF drugs, AP, Assisi Heights, Atlanta Journal-Constitution, Atlanta storm, Austin Daily Herald, Bemidji Pioneer


January 13, 2010

Multiple Sclerosis: A Breakthrough Is on the Way

By Kelley Luckstein

A number of improved treatments will be available soon, and Novartis’ Fingolimod could lead the way…   What doctors can’t guarantee is that the drugs will suppress the illness without triggering infections. “We desperately need new drugs for MS,” says Dr. Mark Keegan, section chair of multiple sclerosis at the Mayo Clinic in Rochester, but […]

View full entry

Tags: multiple scleroris, Novartis


Contact Us · Privacy Policy